Noncompaction cardiomyopathy left ventricular dysfunction: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:


==Overview==
==Overview==
The [[phenotypic expression]] of NCC is variable, and some, but not all patients have left ventricular systolic and or diastolic dysfunction.
The [[phenotypic expression]] of NCC is variable, and some, but not all patients have left ventricular systolic and / or diastolic dysfunction.  [[Arrhythmias]] and embolization are also present.


==Abnormalities in Cardiac Function==
==Abnormalities in Cardiac Function==
*There can be abnormalities in systolic and diastolic function. There can also be hypercontractile dysfunction.
*There can be abnormalities in systolic and diastolic function. There can also be hypercontractile dysfunction.
*These patients are at risk of forming mural thrombus in the left ventricle and embolization.  As a result, all patients with NCC are treated with prophylactic [[aspirin]].  
*These patients are at risk of forming mural thrombus in the left ventricle and embolization.  As a result, all patients with NCC are treated with prophylactic [[aspirin]].  
*There is no communication of the sinusoids with the coronary arteries<ref>Rigopoulos  A,  Rizos  IK,  Aggeli  C, et al.  Isolated left ventricular noncompaction:  an unclassified cardiomyopathy with        severe prognosis in adults. Cardiology.  2002;  98:  25–32.</ref>.
 


==References==
==References==

Revision as of 19:06, 6 August 2011

Noncompaction Cardiomyopathy Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification & Nomenclature

Pathophysiology

Genetics
Embryology
Histology
Left Ventricular Dysfunction
Arrhythmias
Thromboembolism
Neuromuscular Disorders

Epidemiology & Demographics

Screening

Natural History, Complications & Prognosis

Differentiating Noncompaction Cardiomyopathy from other Diseases

Diagnosis

History & Symptoms

Physical Examination

Laboratory Studies

Genetic Testing

Electrocardiogram

Holter Monitoring

Chest X Ray

MRI

CT

Echocardiography

Biopsy

Treatment

Medical Therapy

Surgery

Noncompaction cardiomyopathy left ventricular dysfunction On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Noncompaction cardiomyopathy left ventricular dysfunction

CDC on Noncompaction cardiomyopathy left ventricular dysfunction

Noncompaction cardiomyopathy left ventricular dysfunction in the news

Blogs on Noncompaction cardiomyopathy left ventricular dysfunction

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Noncompaction cardiomyopathy left ventricular dysfunction

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The phenotypic expression of NCC is variable, and some, but not all patients have left ventricular systolic and / or diastolic dysfunction. Arrhythmias and embolization are also present.

Abnormalities in Cardiac Function

  • There can be abnormalities in systolic and diastolic function. There can also be hypercontractile dysfunction.
  • These patients are at risk of forming mural thrombus in the left ventricle and embolization. As a result, all patients with NCC are treated with prophylactic aspirin.


References


Template:WH Template:WS